Heron Therapeutics reaffirms availability of Cinvant, Sustol and Aponvie

Heron Therapeutics reaffirmed the company’s ability to supply Cinvanti injectable emulsion and Sustol extended-release injection for Chemotherapy Induced Nausea and Vomiting prevention and Aponvie for Postoperative Nausea and Vomiting prevention given the temporary shortage of intravenous fluids which is expected as the result of Hurricane Helene. As alternatives to products that require dilution with IV fluids, Cinvant, Sustol and Aponvie are supplied in ready-to-administer formulations that do not require additional dilution with IV fluids in what may be a time of critical shortage. The potential disruption in the supply of intravenously administered fluids is a result of the temporary closure of a major suppliers’ manufacturing site in Marion, North Carolina which was impacted by Hurricane Helene. The Marion facility is believed to supply up to 60% of the IV fluid market in the U.S.